登录查看更多内容

Beyfortus; AstraZeneca; Quell Therapeutics; Pfizer; Samsung Group; UCB; Novartis; Bimzelx

FirstWord Pharma

Where people who know first, go first.

发布日期: 2023年6月9日

+ 关注

Today in FirstWord Pharma 's Industry News newsletter, we cover:

?? FDA panel backs Beyfortus for prevention of RSV in newborns, infants

?? AstraZeneca partners with Quell on Treg cell therapies for diabetes, IBD

?? Pfizer inks over $411-million biosimilar manufacturing deal with Samsung

?? UCB's Bimzelx wins expanded EU approval as US decision looms

?? Sandoz expects pipeline to add $3 billion in sales post-Novartis spin-off

?? Subscribe to FirstWord Pharma's Industry News newsletter & never miss a beat!

?? https://firstwordpharma.com/register

要查看或添加评论，请登录

FirstWord Pharma的更多文章

2023年7月6日

Moderna; mRNA-1345; Teva; AbbVie; Jacobio; F-star; Takeda; JAB-3068; JAB-3312

Today in FirstWord Pharma's Industry News newsletter, we cover: ?? Moderna submits filings for RSV vaccine candidate…
2023年6月29日

Pfizer; NGENLA; CellTrans; Ipsen; Aeras; Gates Foundation; Cognition Therapeutics; Astellas; Bayer

Today in FirstWord Pharma's Industry News ???, we cover: ? US approves Pfizer's paediatric growth hormone deficiency…
2023年6月28日

Regeneron; Eylea; AbbVie; Genmab; Nkarta; Sanofi; Lilly; UCB; Epcoritamab; Epkinly; arabinosylcytosine

Today in FirstWord Pharma Industry News newsletter, we cover: ? FDA declines to approve Regeneron's higher-dose Eylea…
2023年6月27日

Lilly; retatrutide; BMS; Ipsen; Lundbeck; UCB; Pfizer

Today in FirstWord Pharma's Industry News newsletter ???, we cover: ?? Lilly's triple receptor agonist retatrutide…
2023年6月23日

Sarepta; Elevidys; Biogen; Eisai; Roivant Sciences; GSK; Pfizer; Leqembi; RVT-3101; Abrysvo; Arexvy

Today in FirstWord Pharma's Industry News newsletter ???, we cover: ? Sarepta gets FDA nod for DMD gene therapy…
2023年6月21日

DICE Therapeutics; Lilly; Astellas; Pfizer; Agepha Pharma; AstraZeneca; Bavarian Nordic; Novo Nordisk

Today in FirstWord Pharma's Industry News newsletter, we cover: ?? Lilly bets on IL-17 inhibitors with deal to buy DICE…
2023年6月20日

F2G; Shionogi; olorofim; Boehringer Ingelheim; GSK; Arcellx; Gilead; Sensorion; BioSenic; Medsenic; Zantac; CART-ddBCMA

Today in FirstWord Pharma's Industry News newsletter, we cover: ? FDA declines to approve Shionogi, F2G's antifungal…
2023年6月16日

Astellas; Cullgen; Roche; AbbVie; Boehringer Ingelheim; Mersana Therapeutics; Aldeyra Therapeutics; Lilly

Today in FirstWord Pharma's Industry News newsletter, we cover: ?? Astellas adds to protein degrader pipeline with…
2023年6月14日

Seagen; Adcetris; Opdivo; Ipsen; Alladapt Immunotherapeutics; Biogen; Eisai; Bylvay; ADP101; epinephrine; Leqembi

Today in FirstWord Pharma's Industry News newsletter, we cover: ?? Seagen says Adcetris, Opdivo regimen leads to 98%…
2023年6月12日

Chinook Therapeutics; Novartis; Biogen; Eisai; AstraZeneca; Roche; CRISPR Therapeutics; Vertex; Editas Medicine

Today in FirstWord Pharma's Industry News newsletter, we cover: ?? Centers for Medicare & Medicaid Services (CMS) bumps…

See all articles

社区洞察

Biotechnology

How can biopharmaceutical production be optimized for rare diseases?
Healthcare Information Technology (HIT)

How do you collaborate and communicate with other stakeholders and organizations using RxNorm?
Chemical Engineering

How can you purify biopharmaceuticals more effectively?
Bioengineering

How can you ensure the safety and effectiveness of combination products during design review and approval?
Biotechnology

How can you design a safe and efficient drug delivery system?
Bioengineering

How can you use problem solving skills to improve drug development?
Chemical Engineering

What is the best way to predict the pharmacokinetics of a drug?
Biotechnology

What should be considered when designing a biotech product for clinical trials?
Market Access

How do you assess the value proposition of a new drug for different payer segments?
Management Consulting

How can you help a pharmaceutical company rapidly develop new products?

其他会员也浏览了

GLP-1 and its future in peptide therapy

Ella Zhou 3 个月
Biocon Biologics Secures USFDA Approval for New Ophthalmology Biosimilar

MarkNtel Advisors - Market Research Company 6 个月
Merck & Co.; GSK; AstraZeneca; Sanofi; Novocure; Arexvy; Beyfortus; TTFields

FirstWord Pharma 1 年
Kala Pharmaceuticals announces statistically significant results in STRIDE 3 clinical trial evaluating EYSUVIS? for Dry Eye Disease

Dr. Whitney Hauser 4 年
Venturis Therapeutics Inc. Announces Granting of U.S. and Australian Patents for the Therapeutic Angiogenesis in Erectile Conditions

Grant Gordon 4 年
Founding Your Path with Dr. Steven Fox of Akelos Inc.

Avidan Rudansky 4 年
Long back at pharma news to Oct 27

Barbara Obstoj-Cardwell 7 年
Venturis Therapeutics - A positive new chapter in the life of the Company

Grant Gordon 4 年
Eupraxia Pharmaceuticals Announces Updated Positive Clinical Data in EP-104GI RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Inc. 9 个月

FirstWord Pharma的更多文章

Moderna; mRNA-1345; Teva; AbbVie; Jacobio; F-star; Takeda; JAB-3068; JAB-3312

Pfizer; NGENLA; CellTrans; Ipsen; Aeras; Gates Foundation; Cognition Therapeutics; Astellas; Bayer

Regeneron; Eylea; AbbVie; Genmab; Nkarta; Sanofi; Lilly; UCB; Epcoritamab; Epkinly; arabinosylcytosine

Lilly; retatrutide; BMS; Ipsen; Lundbeck; UCB; Pfizer

Sarepta; Elevidys; Biogen; Eisai; Roivant Sciences; GSK; Pfizer; Leqembi; RVT-3101; Abrysvo; Arexvy

DICE Therapeutics; Lilly; Astellas; Pfizer; Agepha Pharma; AstraZeneca; Bavarian Nordic; Novo Nordisk

F2G; Shionogi; olorofim; Boehringer Ingelheim; GSK; Arcellx; Gilead; Sensorion; BioSenic; Medsenic; Zantac; CART-ddBCMA

Astellas; Cullgen; Roche; AbbVie; Boehringer Ingelheim; Mersana Therapeutics; Aldeyra Therapeutics; Lilly

Seagen; Adcetris; Opdivo; Ipsen; Alladapt Immunotherapeutics; Biogen; Eisai; Bylvay; ADP101; epinephrine; Leqembi

Chinook Therapeutics; Novartis; Biogen; Eisai; AstraZeneca; Roche; CRISPR Therapeutics; Vertex; Editas Medicine

社区洞察

其他会员也浏览了

GLP-1 and its future in peptide therapy

Biocon Biologics Secures USFDA Approval for New Ophthalmology Biosimilar

Merck & Co.; GSK; AstraZeneca; Sanofi; Novocure; Arexvy; Beyfortus; TTFields

Kala Pharmaceuticals announces statistically significant results in STRIDE 3 clinical trial evaluating EYSUVIS? for Dry Eye Disease

Venturis Therapeutics Inc. Announces Granting of U.S. and Australian Patents for the Therapeutic Angiogenesis in Erectile Conditions

Founding Your Path with Dr. Steven Fox of Akelos Inc.

Long back at pharma news to Oct 27

Venturis Therapeutics - A positive new chapter in the life of the Company

Eupraxia Pharmaceuticals Announces Updated Positive Clinical Data in EP-104GI RESOLVE Trial for the Treatment of Eosinophilic Esophagitis